Michelson Medical Research Foundation
The Michelson Medical Research Foundation (MMRF) is a private, non-profit philanthropy founded by orthopaedic spinal surgeon and inventor Gary K. Michelson.[1] The foundation aims to solve global health issues by promoting the development of innovative ideas in medicine and bioscience.[2]
History
The foundation was established in 2005 through a $100 million contribution made by Gary K. Michelson.[3]
Initiatives
- The Michelson Post-Injury Glial Scarring Initiative aims to promote the functional recovery of individuals with spinal cord injury. The initiative funds research into the control of glial scarring conducted at the Yale Center for Neuroscience and Regeneration Research.[4]
- The Ethical Medical Research Initiative (a partnership between the Michelson Medical Research Foundation and the Physicians Committee for Responsible Medicine) aims to end the use of animals in alcohol abuse research and the use of dogs in heart failure research across the US.[5]
- The Michelson Fund for NTDs Global Awareness aims to raise awareness of neglected tropical diseases in developing countries, and to encourage the use of available resources to combat their spread. The initiative provides funding for the NTD Special Envoy program.[6]
- The Michelson Neglected Disease Vaccine Initiative has gifted over $3 million to the Sabin Vaccine Institute Product Development Partnership to fund the development of vaccines against neglected tropical diseases.[7]
- The under construction USC Michelson Center for Convergent Bioscience has been gifted over $50 million by the Michelson Medical Research Foundation.[8] The Center will house interdisciplinary researchers from the USC Dornsife College of Letters, Arts and Sciences and the USC Viterbi School of Engineering.[9]
- The University Research and Entrepreneurship Initiative aims to promote innovative research at US Universities. The initiative provides funding for the Wharton Business Plan Competition, the Business Association of Stanford Entrepreneurial Students (BASES) and the MIT $100K Entrepreneurship Competition.[10]
Beneficiaries
Beneficiaries of the Michelson Medical Research Foundation include:
- Paralyzed Veterans of America.[11]
- The Physicians Committee for Responsible Medicine.[12]
- The Sabin Vaccine Institute.[13]
- University of Southern California.[9][14]
- Wharton School of the University of Pennsylvania.[15][16]
References
- ↑ "Michelson Medical Research Foundation". michelsonmedical.org. Retrieved 14 February 2016.
- ↑ "Who We Are". michelsonmedical.org. Retrieved 15 February 2016.
- ↑ "What We Do". michelsonmedical.org. Retrieved 17 February 2016.
- ↑ "Michelson Post-Injury Glial Scarring Initiative". michelsonmedical.org. Retrieved 17 February 2016.
- ↑ "Ethical Medical Research Initiative". michelsonmedical.org. Retrieved 18 February 2016.
- ↑ "Michelson Fund for NTDs Global Awareness". michelsonmedical.org.
- ↑ "Michelson Neglected Disease Vaccine Initiative". michelsonmedical.org. Retrieved 14 February 2016.
- ↑ "Michelson Center for Convergent Bioscience". michelsonmedical.org. Retrieved 14 February 2016.
- 1 2 "Officials break ground on USC Michelson Center for Convergent Bioscience". news.usc.edu. Retrieved 17 February 2016.
- ↑ "University Research & Entrepreneurship". michelsonmedical.org. Retrieved 18 February 2016.
- ↑ "Paralyzed Veterans of America". michelsonmedical.org. Retrieved 18 February 2016.
- ↑ "The Physicians Committee for Responsible Medicine". michelsonmedical.org. Retrieved 18 February 2016.
- ↑ "Michelson Neglected Disease Vaccine Initiative". sabin.org. Retrieved 18 February 2016.
- ↑ "$50 million gift funds convergent bioscience research at USC". news.usc.edu. Retrieved 18 February 2016.
- ↑ "The Wharton Business Plan Competition". michelsonmedical.org. Retrieved 18 February 2016.
- ↑ "RightCare Solutions Wins Wharton Business Plan Competition Michelson Grand Prize with a Diagnostic to Reduce Hospital Readmission Rates". news.wharton.upenn.edu. Retrieved 18 February 2016.
This article is issued from Wikipedia - version of the 8/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.